Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Pharmacotherapy of Diabetic Macular Edema and Retinopathy

  • Chapter
  • First Online:
Drug Delivery for the Retina and Posterior Segment Disease

  • 677 Accesses

Abstract

Diabetes mellitus affects over 20 million people in the United States and that number is growing every year. It is caused by a lack of insulin production which leads to an excess amount of glucose to build up in the bloodstream. Type 2 diabetes mellitus is the most common affecting over 90% of the people with the condition. It occurs when there is a resistance to insulin but can be managed with a healthy lifestyle. Type 1 diabetes mellitus usually is diagnosed in younger adults and occurs when insulin is not produced at all in the body. When these conditions are not properly managed, the patient can develop diabetic retinopathy. Glucose builds up in the bloodstream and causes blood vessels in the eye to swell and produce microaneurysms. Growth factors are released to cause proliferation of new blood vessels in the eye. Fluid starts to leak from these blood vessels into the retinal cavity to cause diabetic macular edema. This disease is the number one cause of blindness in patients diagnosed with diabetes. Proper treatment of these diseases includes management of glucose levels, laser photocoagulation, vitrectomy, anti-VEGF injections, and corticosteroids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(3):S81–90.

    Article  Google Scholar 

  2. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2014;37(1):S14–80.

    Article  Google Scholar 

  3. Atkinson MA, et al. Type 1 Diabetes. Lancet. 2014;383(9911):69–82.

    Article  Google Scholar 

  4. Inzucchi SE, et al. Management of Hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.

    Article  Google Scholar 

  5. Chiang JL, et al. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.

    Article  Google Scholar 

  6. National Center for Chronic Disease Prevention and Health Promotion. Estimates of diabetes and its burden in the United States. National Diabetes Statistics Report; 2017.

    Google Scholar 

  7. Lim EL, et al. Reversal of type 2 diabetes: normalization of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.

    Article  CAS  Google Scholar 

  8. Fineman MS, et al. Retina: color atlas and synopsis of clinical ophthalmology. Wills Eye Inst. 2012;2:44–132.

    Google Scholar 

  9. National Eye Institute. Facts about diabetic eye disease: National Institutes of Health. Maryland, USA: NIH; 2015. https://nei.nih.gov/health/diabetic/retinopathy. Accessed 12 March 2018.

  10. Riberiro L, et al. Characterization of retinal disease progression in a 1-year longitudinal study of eyes with mild nonproliferative retinopathy in diabetes type 2. Invest Ophthalmol Vis Sci. 2015;56:5698–705.

    Article  Google Scholar 

  11. Ortiz-Bautista C, et al. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Med Clin (Barc). 2017;148(6):265–70.

    Article  Google Scholar 

  12. National Eye Institute. Facts about Glaucoma. National Institutes of Health; 2015.

    Google Scholar 

  13. Simó R, et al. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care. 2014;37(4):893–9.

    Article  Google Scholar 

  14. The Beetham Eye Institute. Laser treatment of diabetic retinopathy: Joslin Diabetes Center. Boston, MA: One Joslin Place; 2018. http://www.joslin.org/info/Diabetic_Retinopathy_What_You_Need_to_Know.html. Accessed 12 March 2018.

  15. Lazic R, et al. Treatment of anti-vascular endothelial growth factor—resistant diabetic macular edema with dexamethasone intravitreal implant. J Retin Vitreous Dis. 2014;34(4):719–24.

    CAS  Google Scholar 

  16. Wu L, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4(6):290–4.

    Article  Google Scholar 

  17. The Diabetic Retinopathy Clinical Research Network. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. N Engl J Med. 2015;372:1193–203.

    Article  Google Scholar 

  18. Tan GS, et al. Diabetic Macular Oedema. Lancet Diabetes Endocrinol. 2017;5(2):143–55.

    Article  CAS  Google Scholar 

  19. Rice B, et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216–29.

    Article  CAS  Google Scholar 

  20. Gundogan FC, et al. Diabetic Macular Edema. Pak J Med Sci. 2016;32(2):505–10.

    PubMed  PubMed Central  Google Scholar 

  21. Wazir JF, et al. Visual outcome in patients treated for clinically significant macular edema (CSME). Ophthalmol Update. 2017;15(4):344–7.

    Google Scholar 

  22. Miller AR, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2017;58(3):1499–505.

    Article  Google Scholar 

  23. Park SS, et al. Chapter 9: proliferative diabetic retinopathy. Handbook of Vitreo-Retinal Disorder Management; 2015. p. 73–81.

    Google Scholar 

  24. Bandello F, et al. Retinal Vein Occlusion. Med Retin. 2017;9:32–41.

    Article  Google Scholar 

  25. Nguyen QD, et al. Retinal vein occlusion. Retin Pharmacother. 2016;55:147–53.

    Google Scholar 

  26. Coscas G. Retinal vein occlusions. Macular Edema. 2017;58:139–67.

    Article  Google Scholar 

  27. Reichstein D. Current treatments and preventive strategies for radiation retinopathy. Curr Opin Ophthalmol. 2015;26(3):157–66.

    Article  Google Scholar 

  28. Bastien A. Pseudophakic cystoid macular edema. Ophthalmol Curr Future Dev. 2016;1:261–76.

    Article  Google Scholar 

  29. Spaide RF, et al. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol. 2015;133(1):66–73.

    Article  Google Scholar 

  30. Oh H, et al. Myopic traction maculopathy. Microincision Vitrectomy Surg. 2014;54:204–12.

    Google Scholar 

  31. Tam J, et al. Clinical and translational imaging unit: National Eye Institute. Maryland, USA: NIH; 2017. https://nei.nih.gov/intramural/translational-imaging. Accessed 12 March 2018

  32. Srinivasan PP. Fully automated detection of diabetic macular edema and dry age-related macular degeneration from optical coherence tomography images. Biomed Opt Express. 2014;5(10):3568–77.

    Article  Google Scholar 

  33. Hosoya K, Tachikawa M. The inner blood-retinal barrier: molecular structure and transport biology. Adv Exp Med Biol. 2012;763:85–104.

    CAS  PubMed  Google Scholar 

  34. Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Visual Sci. 2011;52(5):2160–4.

    Article  CAS  Google Scholar 

  35. Warwick AN, et al. Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors. Eye. 2017;31(2):333–41.

    Article  CAS  Google Scholar 

  36. Romero-Aroca P, et al. Diabetic macular edema pathophysiology: Vasogenic versus inflammatory. J Diabetes Res. 2016;2016:1–17.

    Article  Google Scholar 

  37. Stewart MW. Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes. 2016;7(15):333–41.

    Article  Google Scholar 

  38. Gilman JP. Slit Lamp Biomicrography: John Moran Eye Center; 2017.

    Google Scholar 

  39. Thompson JT, et al. Vitrectomy. American Society of Retina Specialists; 2016.

    Google Scholar 

  40. A1C-derived average glucose study group. Hemoglobin A1c. Diabetes Care. 2008;31(8):1473–8.

    Article  Google Scholar 

  41. Sun X, et al. MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells. Clin Orthop Relat Res. 2015;473(3):907–13.

    Article  Google Scholar 

  42. Shotliff K, Davies N. Diabetes Eye Diabetes Chronic Complications. 2012;3:1–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of South Florida College of Pharmacy, Tampa, FL, USA

    Ashley Oake & Yashwant V. Pathak

  2. Morsani College of Medicine, Tampa, FL, USA

    Charles Preuss

Authors
  1. Ashley Oake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Preuss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yashwant V. Pathak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yashwant V. Pathak .

Editor information

Editors and Affiliations

  1. Faculty of Pharmacy, Sankalchand Patel University, Gujarat, India

    Jayvadan K. Patel

  2. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Vijaykumar Sutariya

  3. School of Medicine, Faculty of Health, Deakin University, Victoria, Australia

    Jagat Rakesh Kanwar

  4. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant V. Pathak

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Oake, A., Preuss, C., Pathak, Y.V. (2018). Pharmacotherapy of Diabetic Macular Edema and Retinopathy. In: Patel, J., Sutariya, V., Kanwar, J., Pathak, Y. (eds) Drug Delivery for the Retina and Posterior Segment Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95807-1_2

Download citation

Publish with us

Policies and ethics

Search

Navigation